Botox For Migraines

Chronic migraine is one of the most debilitating neurological conditions affecting adults in the United States, producing throbbing head pain, light and sound sensitivity, nausea, and dizziness that can persist for hours or even days at a time. For patients who experience 15 or more headache days per month — each lasting four hours or more — preventive treatment with onabotulinumtoxinA (Botox) offers a non-surgical, FDA-approved option that has helped reduce headache frequency and severity for hundreds of thousands of patients since its 2010 approval. Unlike acute migraine medications, Botox is a preventive therapy: it does not stop a migraine in progress, but it can meaningfully reduce how often, and how intensely, they occur.

Dr. Maurice Khosh brings a uniquely relevant background to the administration of Botox for chronic migraine. He is dual board-certified by the American Board of Facial Plastic and Reconstructive Surgery and the American Board of Otolaryngology–Head and Neck Surgery — meaning the head, neck, and upper-back regions where migraine Botox is injected are squarely within his everyday surgical practice. A Fellow of the American College of Surgeons (FACS), past president of the New York Facial Plastic Surgery Society, and Clinical Assistant Professor at Columbia University, Dr. Khosh trained in head and neck surgery at Columbia University and completed his facial plastic surgery fellowship at the University of Washington. He has served on the American Academy of Facial Plastic and Reconstructive Surgery’s Board Examination and Continuing Education Committees, contributing to the national standards of practice in his field. He is a perennial Castle Connolly Top Doctor, Best Doctors in America honoree, and Patients’ Choice Award recipient.

A Head and Neck Surgeon’s Approach to Migraine Botox

The standard PREEMPT injection protocol for chronic migraine involves approximately 31 injections distributed across seven specific anatomical zones — the forehead, glabella, temples, back of the head, upper neck, and shoulders. Effective treatment depends on accurate identification of each injection site relative to the underlying nerves and trigger-point muscles. For a physician with thirty years of head and neck surgical experience, these landmarks are not abstract — they are the same structures encountered in everyday clinical practice.

“Botox for migraine isn’t simply Botox in a different location — it follows a specific anatomical protocol, with each injection site selected to interrupt the muscle and nerve pathways that contribute to chronic head pain. Understanding that anatomy intimately matters.” — Dr. Maurice Khosh

How Botox Works to Prevent Migraines

Although the precise mechanism is still being studied, current evidence suggests Botox prevents migraines through several overlapping pathways. When injected into the small muscles around the head, neck, and shoulders, the neurotoxin blocks the release of certain neurotransmitters — including pain-signaling chemicals such as CGRP (calcitonin gene-related peptide) — that contribute to the central sensitization seen in chronic migraine. By reducing nerve activity at these trigger sites, Botox decreases the frequency, intensity, and duration of migraine episodes over time. Clinical studies have shown that many patients experience a meaningful reduction in monthly headache days after two complete treatment cycles.

Who Is a Candidate for Botox Migraine Treatment

Botox is FDA-approved specifically for adults with chronic migraine — defined as a history of headaches on 15 or more days per month, with at least 8 of those days involving typical migraine symptoms, sustained for at least three months. Insurance approval generally requires documentation of this pattern, along with prior trials of at least two other preventive medications. Patients who may benefit from migraine Botox include those who:

• Meet Chronic Migraine Criteria: Experience 15 or more headache days per month with attacks lasting four hours or longer
• Have Tried Other Preventives: Have not achieved meaningful relief from anti-seizure medications, antidepressants, blood pressure medications, or CGRP inhibitors
• Prefer a Non-Daily Option: Want a preventive treatment given every 12 weeks rather than daily oral medication
• Tolerate Injectable Treatment: Are comfortable with multiple small injections every three months
• Are Free of Contraindications: Have no history of allergic reaction to botulinum toxin or active neuromuscular disease

What to Expect During Migraine Botox Treatment

A migraine Botox treatment session at Dr. Khosh’s Park Avenue office typically takes about 15 minutes. Using a fine-gauge needle, Dr. Khosh delivers approximately 31 small injections — totaling around 155 units of Botox — across the seven anatomical zones outlined in the PREEMPT protocol. Most patients describe each injection as a brief pinch, comparable to the sensation of a small needle stick. There is no anesthesia required and no downtime; patients can drive themselves home and return to normal activities immediately. It typically takes 10 to 14 days to begin noticing reduced headache frequency, with the full preventive effect developing over several weeks. Many patients see continued improvement after their second or third treatment cycle, as the cumulative effect builds.

Frequently Asked Questions About Botox for Migraines

How long does it take to see results from migraine Botox?

Most patients begin to notice fewer headache days within 10 to 14 days after their first treatment, but the full preventive effect often takes two to three treatment cycles to fully develop. Clinical research has shown that many patients experience continued improvement with consistent treatment over six to nine months.

How often do I need to receive treatment?

The FDA-approved protocol calls for Botox injections every 12 weeks. This interval matches how long the medication remains active in the targeted nerves and muscles. Spacing treatments closer than 12 weeks is not recommended and does not improve results.

Will my insurance cover Botox for migraines?

Because Botox is FDA-approved for the prevention of chronic migraine, most major insurance plans — including Medicare and Medicaid — provide coverage for qualifying patients. Insurance carriers typically require documentation that you meet the chronic migraine criteria and that you have tried at least two other preventive medications without significant benefit. The office can help determine coverage during your consultation.

Is Botox an option if I have fewer than 15 headache days per month?

No. Botox is not FDA-approved for episodic migraine, which is defined as 14 or fewer headache days per month. Patients with episodic migraine should discuss other preventive options with their neurologist or headache specialist. Dr. Khosh can help determine whether your headache pattern meets the criteria for chronic migraine treatment.

Will Botox for migraines affect my facial expression?

Migraine Botox is injected primarily into the deeper muscles of the forehead, temples, back of the head, and neck — not into the superficial muscles targeted for cosmetic Botox. Some patients notice modest smoothing of forehead lines as a secondary benefit, but the doses and injection sites used in the migraine protocol are designed to address pain pathways rather than wrinkles.

Can I combine Botox with my current migraine medications?

Yes. Botox is a preventive treatment and is often used alongside acute migraine medications (such as triptans) and other preventive therapies. Recent research has also explored combining Botox with CGRP inhibitors for patients who only partially respond to either treatment alone. Dr. Khosh coordinates care with your neurologist or primary care physician to ensure your full treatment plan is safe and effective.

Why Patients Choose Dr. Khosh for Migraine Botox

• Head and Neck Anatomy Expertise: Treatment delivered by a dual board-certified surgeon whose daily practice involves the same anatomical regions targeted by the PREEMPT protocol
• Precise Injection Technique: Thirty years of surgical experience translates into accurate placement and consistent dosing across treatment cycles
• Comprehensive Evaluation: Each candidate is carefully screened against FDA criteria and coordinated with the patient’s neurologist or primary care physician
• Insurance Navigation Support: The office assists with documentation and prior authorization for qualifying patients
• Park Avenue Convenience: Treatments are completed in approximately 15 minutes at the practice’s Upper East Side office

Schedule Your Consultation in Manhattan

If you experience 15 or more headache days per month and have not found lasting relief through other preventive treatments, Botox for chronic migraine may be a meaningful option to explore. Dr. Khosh offers consultations to review your headache history, evaluate your candidacy under FDA criteria, and coordinate with your existing care team to determine whether migraine Botox fits into your treatment plan. To schedule a consultation at Dr. Khosh’s Park Avenue office in New York City, call (212) 339-9988 or contact us online.